At a Glance
Dosage
oral
| Level | MET | 1P-LSD |
|---|---|---|
| Threshold | 40 mg | 15 µg |
| Light | 60–120 mg | 25–75 µg |
| Common | 120–150 mg | 75–150 µg |
| Strong | 150–200 mg | 150–300 µg |
| Heavy | 200 mg | 300 µg |
Only in MET
insufflated
| Level | Dose |
|---|---|
| Threshold | 5 mg |
Duration
oral
MET
oral
Total: 4 hrs – 6 hrsAfterglow
Onset1 hrs – 2 hrs
Come Up30 min – 1 hrs
Peak1.5 hrs – 2.5 hrs
Offset
Effects
Safety
Interaction: MET + 1P-LSD
Low Risk & Synergy
Cross-tolerance exists; effects compound
MET — Dangerous Interactions
No dangerous interactions recorded.
1P-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between MET and 1P-LSD?
MET is classified as a Psychedelic (Substituted tryptamines) while 1P-LSD is classified as a Psychedelic (Lysergamides). They share 53 effects in common, with 14 effects unique to MET and 33 unique to 1P-LSD.
Is it safe to combine MET and 1P-LSD?
The interaction between MET and 1P-LSD is classified as "Low Risk & Synergy". Cross-tolerance exists; effects compound Always research interactions thoroughly before combining any substances.
Which is stronger, MET or 1P-LSD?
At common doses via oral, MET is typically dosed at 120–150 mg while 1P-LSD is dosed at 75–150 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.